![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 6, 4199-4205, February 8, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S-crystallin C-terminal
Domain*
§,
,
,
From the
School of Crystallography, Birkbeck College,
Malet Street, London WC1E 7HX, United Kingdom and the ¶ Department
of Biochemistry, University of Nijmegen, 6500 HB
Nijmegen, The Netherlands
Received for publication, October 18, 2001, and in revised form, November 6, 2001
| |
ABSTRACT |
|---|
|
|
|---|
The lens crystallins are protein molecules that need to last a
lifetime, because they are found in cells that have no protein synthetic or degradation machinery (1). The leading senile cataract
hypothesis is that aged non-native crystallin molecules overwhelm the
binding capacity of the small heat shock protein The crystallins are a well studied family of proteins for which there
are several three-dimensional structures (4) as well as thermodynamic
and kinetic data on folding/unfolding (5-7). The polypeptides of the
~13-member There are seven genes coding for Several x-ray structures of So far for Protein Expression--
The human
The HGSC plasmid DNA, coding for residues 91-177 (topologically
equivalent to residues 86-172 of Protein Isolation--
The highly expressed protein was isolated
from the soluble fraction. Whole cell lysate was prepared from the
thawed pellet by addition of DNase I and MgCl2 to the
suspension giving final concentrations of 10 µg/ml and 10 mM, respectively, followed by sonication on ice using 10-s
pulses with cooling in between. The pellet was spun down at 20,000 rpm
for 30 min at 4 °C before dialyzing the supernatant overnight at
4 °C with stirring against buffer A (25 mM Tris-HCl, pH
8.0, 1 mM EDTA, 1 mM dithiothreitol). The solution was then filtered through a 0.4-µm nitrocellulose filter followed by a 0.2-µm nitrocellulose filter before being loaded onto a
Hiload 16/10 Q Sepharose High Performance column (Amersham Biosciences,
Inc.). The column was run at 4 ml/min on a Gradifrac with the following
program: 1) 20 ml of 100% buffer A; 2) gradient from 0-70% buffer B
(buffer B was buffer A with 1 M NaCl) over 160 ml; 3) 60 ml
of 100% buffer B; and 4) 100 ml of 100% buffer A. The HGSC peak
eluted at about 15% buffer B, in line with the predicted pI of 6.0. The identity of the protein was confirmed by electrospray mass
spectrometry with the measured mass of 10,412 being in close agreement
with the calculated mass of 10,414 and indicating that the initiating
methionine had been cleaved. The HGSC protein fractions were
concentrated to ~10 mg/ml and equilibrated against 25 mM
Bis-Tris-propane HCl, pH 7.5, using an Amicon (Millipore, Watford,
Hertfordshire, UK) cell equipped with a YM3 membrane. The concentrated
protein was stored at
The size of the protein was estimated using chromatography on a
Superose 12HR 10/30, using 25 mM Bis-Tris-propane HCl, 0.2 M NaCl, pH 6.5 or 8.0, as running buffer. The HGSC eluted
at 15.3 ml, over a wide range of protein concentration application
(0.2-6.5 mg/ml) at both pH 6.5 and 8.0. For comparison, full-length
bovine Crystallization--
The crystals were grown using the hanging
drop vapor diffusion method with conditions for crystal growth
optimized from Hampton (Laguna Niguel, CA) Crystal Screen II condition
13, with polyethylene glycol monomethylether 2000 as precipitant. 1 µl of protein at ~10 mg/ml 25 mM Bis-Tris-propane HCl,
pH 7.5, was added to 1 µl of well solution containing 0.2 M ammonium sulfate, 0.1 M sodium acetate, pH
5.0, and 20-28% polyethylene glycol monomethylether 2000. The optimum
crystals, formed at 24% polyethylene glycol monomethylether 2000 after
4 days growth at room temperature, were hexagonal bipyramidal with
dimensions of ~0.3 × 0.1 × 0.1 mm3.
Data Collection and Processing--
Intensity data to 2.4 Å were collected from a cryo-cooled (100 K) crystal using the Daresbury
SRS source at Station 9.6 using an ADSC imaging plate. No
cryoprotectant was added. The data were processed using the program
MOSFLM (29). Scaling was carried out with the program SCALA (30), and
the data were truncated with TRUNCATE (31). The crystals were either
space group P6122 or P6522 with two molecules
in the asymmetric unit assuming a solvent content of 61% (Vm = 3.15 Å3/dalton). The crystal data and statistics from data
processing are listed in Table I.
Structure Determination--
Molecular replacement was
undertaken with the program AMoRe (32) with the B chain coordinates
from the bovine Structure Refinement--
Refinement of the structure was
undertaken using CNSsolve version 0.9 (33). The reflections were
divided, at random, into working and test (7.5% of the data) sets, to
allow both the crystallographic and free R factors to be
followed. The test set of reflections was excluded from the map
calculations. Early in refinement, the noncrystallographic symmetry at
the dimer interface was maintained by use of restraints (initial
noncrystallographic symmetry restraints were 20 kcal/mol). Both
simulated annealing and minimization methods were tried for refinement,
with a maximum likelihood target using amplitudes. The refinement
method giving the best reduction in the R factors for a
cycle was chosen, and individual isotropic B-factor refinement was then
undertaken. In each cycle, both 2Fo
The final solution contains two molecules of human Solvent Accessibility--
The program NACCESS (39) was used to
calculate solvent accessible surface areas using the default probe
radius of 1.4Å.
Figures--
The figures were produced using the programs MOLMOL
(40) and POVRAY version 3.1.
Human
The residues in the interface between the two domains in HGSC are shown
in Fig. 2. It should be noted that the
residue numbers used here are based on the alignment of the domain to
Tyrosine Corner Structure--
It is apparent from a superposition
of three kinds of Dimer-Dimer Interactions in Human
It is residues in the smaller HGSC interface 3 that show the major
conformational differences when compared with other The Cysteine and Amide Sites--
The solvent accessibilities
of Cys109 (Cys114 in
The two-domain human
Two other amide containing residues are involved in lattice contacts:
Gln115(120) and Gln101(106).
Gln115(120) hydrogen bonds to Thr105(110) and
Thr106(111) and is close to Glu107(112) in
interface 1 (Fig. 4A). This residue is also involved in a similar interaction in the lattice of the bovine The human The tyrosine corner is an extremely conserved structural feature of the
The human Because deamidation is a commonly observed post-translational
modification in the long-lived crystallins, it is possible that the
addition of a negative charge could disturb the short range repulsive
interactions of human Human It has been shown that the tryptic peptide containing
Asp138(143) is deamidated when isolated from human
cataractous lens proteins (44), whereas when the corresponding peptide
is isolated from the fetal-embryonic region of aged transparent human
lenses, it is not deamidated (46). Asp138(143) is in the
region of the domain dimer interface but has a moderate solvent
exposure (Fig. 5). The addition of a negative charge in place of the
neutral asparagine is likely to perturb Glu114(119), but
weakly because it is some distance away. Recently, more than 40% of
residue Asn138(143) in human cataractous lenses has been
identified as being in the
S-crystallin is a major human lens protein
found in the outer region of the eye lens, where the refractive index
is low. Because crystallins are not renewed they acquire
post-translational modifications that may perturb stability and
solubility. In common with other members of the 
-crystallin
superfamily,
S-crystallin comprises two similar
-sheet domains.
The crystal structure of the C-terminal domain of human
S-crystallin
has been solved at 2.4 Å resolution. The structure shows that in the
in vitro expressed protein, the buried cysteines remain
reduced. The backbone conformation of the "tyrosine corner" differs
from that of other 
-crystallins because of deviation from the
consensus sequence. The two C-terminal domains in the asymmetric unit
are organized about a slightly distorted 2-fold axis to form a dimer
with similar geometry to full-length two-domain family members. Two
glutamines found in lattice contacts may be important for short range
interactions in the lens. An asparagine known to be deamidated in human
cataract is located in a highly ordered structural region.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-crystallin (also
found in the lens), resulting in aggregation and formation of light
scattering centers (2). Detailed molecular information from selected
crystallin domains and proteins is needed to model their unfolding and
characterize their likely ensemble biophysical properties, particularly
the early unfolding intermediates that have been hypothesized to bind
to
-crystallin (3). As a first step toward providing detailed
molecular information on a major human lens crystallin involved in
cataract, we have solved the x-ray crystal structure of the C-terminal
domain from human
S-crystallin.

-crystallin superfamily each comprise similar
~10-kDa N- and C-terminal domains that are themselves formed from two
symmetrically organized Greek key motifs. In all cases, the N- and
C-terminal domains pair about a similar pseudo-2-fold axis, with the
domains in monomeric
-crystallins being covalently connected,
whereas domain swapping can lead to dimerization in
-crystallins
(8).
-crystallins in vertebrate lenses
(9), and they consist of the closely related
A-
F family and the
more distantly related but more conserved
S-crystallin. The
expression patterns of the family of
-crystallins appear to be
correlated with the formation of the decreasing refractive index
gradient from the center to the cortex of the adult lens (4, 10). The
propensity of certain
-crystallins to easily form a concentrated
phase (11), such as the high Tc
-crystallins that are
enriched in the core region of the lens, probably reflects their
"attractive" interactions (12).
S-crystallin, located in the low
refractive index outer regions of the lens, is characterized by more
repulsive intermolecular interactions (13). The molecular basis for the
stability of these long-lived structural proteins, along with their
solution intermolecular interactions that govern solubility and phase
separation behavior, are areas of cataract research.
A-F crystallins are now
known, and they all show very similar two-domain pairing about a
hydrophobic interface that contributes toward stability (14-17).
S-crystallin is a major structural protein in the human eye lens
(18). Human and bovine
S-crystallins and their isolated domains are
very stable and show two-state unfolding, allowing detailed
quantitative thermodynamic properties of the proteins to be evaluated
(19). Computer simulations of heat-induced unfolding of bovine
B-crystallin also indicate high stability and furthermore suggest
that the first stage of unfolding involves the dissociation of the
paired domains (20). Conformational changes to aging crystallins can derive from a variety of covalent changes. Oxidation of cysteine and
methionine residues have been detected in human crystallins (21).
Deamidation of human
-crystallins is correlated with aging (22, 23)
and with increased insolubilization of crystallins, particularly
S
(21). Deamidation alters the charge balance, adding a negative charge
to a previously neutral area, but it is also thought to mark the
nonenzymic formation of isomers such as
-aspartate that would alter
the backbone covalent structure (24).
S-crystallin, only the C-terminal domain of the bovine
protein has been solved by x-ray crystallography (25), showing how two
domains self-associate to form a dimer in an analogous way to that of
the native two-domain
-crystallins, although the pairing is less
symmetrical. Surprisingly, one of the domains has an altered
conformation in its tyrosine corner, a usually highly conserved feature
of most
-sandwich proteins (26). In fact, the tyrosine corner has
been proposed as a possible folding nucleus in a prokaryote protein
with a related 
-crystallin fold (27), although this has not been
universally supported (28). Because it is unclear to what extent the
lattice interactions in the crystal structure influenced pairing and
conformation, further three-dimensional structures are required. Here
we show that the C-terminal domains of human
S-crystallin pair about a slightly distorted 2-fold axis to form a dimer with both tyrosine corners in a nonstandard conformation.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
S-crystallin C-terminal
domain (HGSC)1 was cloned in
the pET3a vector essentially as described for the C-terminal domain of calf
S-crystallin (25). The novel initiation codon was
introduced in the human
S sequence (19) at a position that replaced
the first glycine in the linker sequence by PCR-mediated mutagenesis
using the following primers: GTTCATCTGCCTCATATGGGCCAGTATAAG (forward)
and GGATCCATGTCATTACTCCACAATG (reverse).
B-crystallin) was transformed into
Escherichia coli strain BL21(DE3) pLysS competent cells. Colonies were picked to inoculate and grown overnight at 37 °C with
shaking in 10 ml of 2YT medium (5 g/liter NaCl, 10 g/liter yeast
extract, 16 g/liter peptone 140) with 10 µl of ampicillin (100 mg/ml)
and 15 µl of chloramphenicol (34 mg/ml). Large scale growth was
performed with an overnight culture of 500 ml of 2YT medium containing
250 µl of ampicillin (50 mg/ml) after inoculation at 100:1 from the
10-ml overnight growths. The flasks were shaken at 37 °C and induced
by the addition of 250 µl
isopropyl-
-D-thiogalactopyranoside after the culture was
grown to an A550 of 0.4-0.6 (3-4 h).
Growth was continued overnight, whereupon cells were harvested by
centrifugation at 5000 rpm for 15 min at 4 °C. The pellets were
resuspended in 10 ml of 25 mM Tris-HCl, pH8.0, 10 mM EDTA, 50 mM glucose with a protease
inhibitor (5 µl of Pefabloc (Merck)) and frozen at
20 °C.
20 °C.
S-crystallin at pH 8.0 elutes at 14.4 ml, in agreement with
the monomeric nature of the C-terminal domain of human
S in
solution, as determined using ultracentrifugation (19).
Crystallographic data
S-C domain (25) as a search model. Data from 15-2.4
Å were used in both the rotation and translation function searches
with a Patterson cut-off radius of 15 Å and a radius of integration of
0.75% (the maximal distance from the center of mass being 21.5 Å). A
successful solution was found indicating two molecules in the
asymmetric unit, using the P6522 space group, with a
correlation coefficient of 63.7 and an R factor of
42.3%.
Fc and Fo
Fc electron density maps were calculated, and
manual rebuilding was undertaken using the program O (34). Water
molecules were added using the CCP4 (35) programs PEAKMAX and WATPEAK to select potential sites. Some later rounds of refinement were undertaken using the CCP4 programs REFMAC (36) and ARP_WARP (37)
interspersed with CNSsolve refinement. Noncrystallographic symmetry
restraints were lowered to 5 kcal/mol and finally removed. The final
values for a crystallographic R factor of 21.6% and for a
free R factor of 26.4% were obtained after 35 cycles of refinement.
S-crystallin
C-domain (A and B) in the asymmetric unit, together with 90 water
molecules. The statistics after refinement are given in Table
II. Electron density for all the residues
is visible, with just some side chain density remaining unclear. The
Ramachandran plot from PROCHECK (38) shows 86.2% of the residues in
the most favored regions and 13.8% in the additional allowed regions.
The coordinates have been deposited in the RCSB protein data bank, under code number 1ha4.
Refinement statistics
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
S-crystallin C-terminal Domain Forms a "Dimer" in the
Crystal Lattice--
The refined electron density shows that the two
molecules of the HGSC in the asymmetric unit have a very similar
structure (backbone root mean square deviation of 0.29 Å), and they
are very similar to bovine
B-crystallin C-terminal domain (BGBC) (backbone root mean square deviation of 0.8 Å). The two HGSC domains form a dimer with a rotation of 176.5° between the two chains (red in Fig. 1A).
This 2-fold pairing of two C-terminal domains is similar to the N- and
C-terminal domain pairing in other polypeptides of the

-crystallin family and is considered to reflect the origin of the
family from an ancestral homodimer of single domains (41). Further
evidence for the ancestral homodimer model is provided by the crystal
structure of the C-terminal domain of bovine
B-crystallin in which
the C-terminal tyrosine was deleted. The two domains paired about a
slightly distorted noncrystallographic 2-fold axis (BGBC,
blue in Fig. 1A) and are readily superposed on
the native 2-domain
B-crystallin (42). However, when the C-terminal
domain of bovine
S-crystallin was solved, the two molecules in the
asymmetric unit were found to pair in a broadly similar way (BGSC,
green in Fig. 1A), but the 2-fold is distorted by
around 20 °C (25).

View larger version (21K):
[in a new window]
Fig. 1.
Dimer of human
S-crystallin C-terminal domains. A,
a superposition of the HGSC dimer, the BGSC dimer, and the BGBC (42)
dimer. The backbone is colored according to the protein. The
black arrows point to the tyrosine corners where the
proteins show the largest differences, whereas the gray
arrows point to residues 99-103, which are involved in
dimer-dimer interactions. B, sequence alignment of
the C-terminal domains of human (HGSC) and bovine
S (BGSC) with
bovine
B-crystallin (BGBC). The residues mentioned in the text as
being involved in interactions between domains are
highlighted. The tyrosine corner sequence is
underlined.
B-crystallin not from the
S-crystallin sequence (Fig.
1B). In common with other 
-crystallin paired domain
interfaces, there is a central hydrophobic patch (shown in
green) surrounded by polar residues that make specific
interactions. For example, in the HGSC dimer, there are two ion pairs
between Asp147 and Arg168 on each side of the
noncrystallographic axis, whereas in the BGSC distorted dimer, only one
ion pair can form (see Fig. 4 in Ref. 25). A cluster of interactions is
close to the 2-fold axis: each Gln143 and
Glu172 side chain interacts with backbone polar atoms of
its symmetrically related partner, and each Arg142
interacts with its symmetrically related partner side chain. The
only sequence difference between the two species at the interface is
Val130 in human that replaces alanine in the bovine and is
likely to contribute to the differing symmetries.

View larger version (25K):
[in a new window]
Fig. 2.
S C-domain dimer
interface. The backbone of chain A (black) and chain B
(gray) are shown with interface residues colored such that
the acidic residues (Asp147 and Glu172) are in
red, the basic residues (Arg142 and
Arg168) are in blue, the hydrophobic residues
(Val130, Leu145, and Ile170) are in
green, and the polar residue (Gln143) is in
purple.
-crystallin C-terminal domain dimers that there
are two regions, calculated using difference distance plots (43), where
the domain conformation differs: the tyrosine corners and a dimer-dimer
interface region (Fig. 1A). When tyrosine corners from four
C-terminal domains of members of the 
-crystallin superfamily
(HGSC, BGSC, BGBC, and the C-terminal domain of bovine
B2-crystallin) are compared, HGSC has a backbone conformation that
follows that of the BGSC A chain rather than the more common
conformation seen in BGBC and the C-terminal domain of bovine
B2-crystallin. Fig. 3A
shows a comparison of the HGSC tyrosine corner with that from BGBC. The
unusual conformation is centered near residue 148 where
B has
proline and
S has lysine. In the "standard" conformation, the
tyrosine (151) hydroxyl oxygen hydrogen bonds with the main chain N-H
of Asp147 (bond length, 2.4 Å). In HGSC, the tyrosine
hydrogen bonds with the main chain N-H of Lys148 (bond
length, 1.96 Å). The new corner conformation results in different
positions for the exposed positive charges of lysines 148 and 149 (Fig.
3A).

View larger version (19K):
[in a new window]
Fig. 3.
The tyrosine corner in human
S-crystallin. A, the two chains of
the human
S C-terminal domains and the two chains of bovine
B
C-terminal domains have been superposed to show the different hydrogen
bonding patterns in the two types of tyrosine corner. The
yellow hydrogen bond occurs in the standard conformation
from BGBC (in red), where the side chain oxygen of
Tyr151 hydrogen bonds to the main chain N-H of
Arg147, this conformation being the same as that found in
the B chain of BGSC. The turquoise hydrogen bonds occur in
the unusual conformation from HGSC (in blue), where
Tyr151 hydrogen bonds to Lys148 main chain
nitrogen. This conformation is the same as that found in the A chain of
BGSC. B, an alignment of some human 
-crystallin
C-terminal domain tyrosine corner sequences shows the conservation of
at least one of Pro148 or Gly149 (shown in
red) in all sequences except for
S.
S-C--
There
are three different interdimer interfaces present in the crystal
lattice (Fig. 4). The solvent accessible
surface areas have been calculated for the single HGSC chains, for the
AB dimer on its own (Chains A and B together), and for the AB dimer
with its symmetrically related partners. These data are shown in Table III. When the amounts of buried surface
area in the three lattice interfaces are compared with the area buried
within the dimer, it can be seen that the interface between the chains
in the dimer buries 10.9% of the monomer surface, whereas lattice
interfaces 1, 2, and 3 bury 9.3, 6.6, and 2.8%, respectively.
Interface 1 is thus nearly as extensive as the dimer interface and is
similar to one of the four lattice interfaces found in the bovine
lattice (data not shown). His117, a residue in the long
loop region between strands c and d of the first Greek key motif,
participates to some extent in all three interfaces (Fig. 4).

View larger version (36K):
[in a new window]
Fig. 4.
Residues that dominate lattice
interactions. The dimer in the asymmetric unit makes three lattice
interactions. The green residue His117(122) is
involved in all three, with involvement of the purple
residues Gln115(120) in interface 1 (A) and
Gln101(106) in both interfaces 2 (B) and 3 (C). These residues are likely to contribute toward the
short range interactions in the normal human lens.
Solvent-accessible surface areas
-crystallin C-terminal domains (Fig. 4C). Only one of the residues that
differs between the human and the bovine sequences is involved in
lattice interactions for the human form. This is tyrosine 103 that
interacts with conserved glutamine 101 in interface 3, whereas this
residue is a histidine in the bovine protein.
S numbering) 3.7 Å2 and Cys124 (Cys129 in
S
numbering) 0.0 Å2 are low because they are buried in the
domain core with their SG atoms 13 Å apart. There is no indication of
oxidation. The exposure of the amide containing amino acids, calculated
for the A chain from an AB dimer, are ranked in order of accessibility: Gln87(92) 130.0 Å2; Gln115(120),
105.1 Å2; Gln101(106), 100.1 Å2;
Asn138(143), 97.2 Å2; Gln165(170),
50.9 Å2; Gln91(96), 30.6 Å2; and
Gln143(148), 18.4 Å2 (Fig.
5). The least accessible,
Gln143(148), is buried in the dimer interface and would
likely be packed against the N-terminal domain in the intact two-domain
S molecule. The side chain of Asn138(143), a residue
shown to be deamidated in human cataract (44), is not involved in
hydrogen bonding to either backbone or side chain atoms of neighboring
residues; therefore deamidation will not destabilize the molecule by
disruption of hydrogen bonds. At neutral pH, the C-terminal domain of
S-crystallin has a charge of
1, and the addition of another
negative charge by deamidation of Asn138(143) may
contribute to a decrease in stability. Charged residues within 10 Å (chosen as a value for the limit of electrostatic effects), which may
be perturbed by the addition of a negative charge are: Glu114(119), Glu135(140),
Arg140(145), and Arg168(173). The most
important of these interactions is likely to be that of
Asn138(143) with Glu114(119) because the
closest atoms of these two residues are the termini of the side chains
(7.2 Å apart).

View larger version (39K):
[in a new window]
Fig. 5.
Location of the amide residues. The side
chains of asparagine (green) and glutamine (red)
residues appended to a backbone trace of HGSC show their even
distribution over the domain surface. Gln101(106) and
Gln115(120), the amides involved in lattice interactions,
have similar surface accessibilities as Asn138(143), which
is known to be deamidated in cataract. Gln101(106) and
Asn138(143) are situated on each of the highly ordered
-hairpin loops.
S-crystallin was modeled using the complete
bovine
B-crystallin as a template, with the C-terminal domain
replaced by the human
S coordinates and the residues in the N-domain
mutated to match the human
S sequence. In this model, the only
residue on the N-terminal domain that is within 10 Å of
Asn138(143) is Met69(73), with the main chain
carbonyl of Asn138(143) being 8.8 Å from the side chain of
Met69(73). This interaction with methionine is also seen in
the x-ray structures of bovine
D-,
E-, and
F-crystallins, but
at a distance of 6.3-6.5 Å, and it is the only residue from the
N-terminal domain within 10 Å of Asn138(143). Deamidation
of Asn138(143) is thus unlikely to perturb electrostatic
interactions in the N-terminal domain.
S-crystallin C-terminal domain dimer. In HGSC interface 2, Gln101(106)
from chain A interacts with the main chain of two residues from chain
B: Arg119(124) and Glu120(125) (Fig.
4B) and in interface 3 (Fig. 4C), it interacts
with its symmetrically related partner as well as with
Met102(107) and Tyr103(108).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
S-crystallin C-terminal domain forms dimers in the
crystal lattice (although not in solution) using a similar interface to
those observed between N- and C-terminal domains in other

-crystallins and is likely to form a similar intramolecular
interface with its own N-terminal domain. The dyad is more exact than
in the corresponding bovine
S construct. The recreation of these
2-fold interactions between single domains underscores the idea that domain pairing is an ancestral dimer trait. However, without the covalent linker, the local concentration of a single domain is insufficient to form a dimer in solution (19). The weakness of the
interface interaction renders it susceptible to deformation, and it is
the first likely hydrophobic surface to become water exposed during
denaturation, in line with computer simulated unfolding studies of
B-crystallin (20).

-crystallin fold. In common with other
-sandwich domains, it
occurs only once in the domain, even though the 
-crystallin domain is made from two similar Greek key motifs (Fig. 1B).
Here it is shown that in the human
S-crystallin C-terminal domain, the tyrosine corner conformation in both partners of the dimer is
nonstandard. In the corresponding bovine
S-crystallin structure, where the two domains in the asymmetric unit (chains A and B) pair
about a distorted 2-fold axis, the major conformational difference between the chains is in the tyrosine corner, with chain A having an
unusual conformation. However, it was not possible to ascertain whether
this was due to the distorted 2-fold pairing and/or was a consequence
of crystal lattice interactions (25). We hypothesize that the tyrosine
corner structure seen in both chains of the human
S-crystallin
C-terminal domain, as well as the A chain of the bovine
S-crystallin
C-terminal domain, is the favored conformation for
S-crystallins.
The consensus sequence for the tyrosine corner is
LXPGXY, whereas in
S-crystallin C-terminal domain it is LDKKEY with the lysine pair that replaces proline-glycine increasing the energy of the standard tyrosine corner polyproline II
conformation. The more usual
-crystallin conformation found in the
crystal form of the B chain of the C-terminal domain from bovine
S-crystallin is probably being stabilized by the side chain of
Lys148(153). This forms a salt bridge with the C-terminal
carboxylate of chain A, giving a compensation for the higher energy
conformation of the backbone. Now that the new conformation has been
seen in a
S-crystallin in a different lattice, it is likely to be
independent of a secondary lattice effect. It will be interesting to
ascertain whether this new conformation contributes to the lower
stability of
S-crystallin toward denaturants compared with
B-crystallin (19) and/or affects the folding.
S C-terminal domain sequence is very similar to the bovine
(93% identical). Although the two species of crystals are grown under
very similar conditions, they have different space groups (human,
P6522; bovine, P6122) and form two kinds of
dimer, one almost perfect and one distorted. Only one of the residues that differs between the human and the bovine sequences is involved in
lattice interactions, this being Tyr103(108) in the human
form. This bulky residue occupies a position at an extremity of the
molecule, a position that is involved in lattice interactions in other
-crystallins (14). It is likely to be responsible for the differing
space groups and hence different lattice contacts in
S-crystallin
and may play a role in the short range interactions in the eye lens.
S-crystallin (13). Two highly exposed
glutamines (at positions 101(106) and 115(120)) are involved in lattice
interactions, the latter in both human and bovine crystal structures.
Deamidation of these glutamines may thus have implications for the
interactions of
S-crystallins in the lens.
S-crystallin has to last a lifetime and thus requires both
thermodynamic and kinetic stabilization. A recently described mouse
S-crystallin gene that carries a point mutation provides a model for
how a properly folded but destabilized protein can cause cataracts
(45). Mechanisms for loss of stability leading to aggregation and light
scattering in human senile cataracts have invoked post-translational
modifications involving cysteine oxidation and deamidation. The two
cysteines, Cys109(114) and Cys124(129), that
are buried in the C-terminal domain of human
S-crystallin remain
reduced during crystal growth without the addition of reducing agents
in keeping with the stability of the native domain fold. An interesting
question is whether deamidation contributes to domain destabilization
and hence increases the chances of the buried cysteines becoming
exposed and available for cross-linking.
-aspartate form (47). Identification of
this modification, along with the occurrence of racemization at this
site, further substantiates the hypothesis that deamidation can occur
via a preferred succinimidyl intermediate (48). Deamidation
is thus a useful marker of a more radical structural change to
the protein that involves addition of extra carbons to the polypeptide
backbone and tends to be correlated with flexibility of the protein
backbone chain (24). It is significant that Asn138(143) is
in the highly ordered folded
-hairpin structure that is involved in
maintaining the tertiary 
-crystallin fold (4). If deamidation were to occur to the native protein at this site leading to an altered
covalent backbone structure, it would likely destabilize the
S-crystallin domain. Because this residue is resistant to deamidation in the normal aged human
S-crystallin (46), it is
unknown whether the molecule has first to be unfolded prior to
deamidation or whether other cataractogenic factors are involved that
favor deamidation, which then leads to unfolding.
| |
ACKNOWLEDGEMENTS |
|---|
We acknowledge Dr. Claire Naylor for help with data collection, processing, and refinement, Dr. Ajit Basak for help with crystallization and data collection, and the staff at station 9.6 at the Daresbury laboratory.
| |
FOOTNOTES |
|---|
* This work was supported by BioMed Program of the European Community Grant BMH4-CT98-3895 and by the Medical Research Council and the Biotechnology and Biological Sciences Research Council London Structural Biology Center.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The atomic coordinates and structure factors (code 1ha4) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
§ Supported by a BBSRC studentship. To whom correspondence should be addressed. Tel.: 44-20-7631-6869; Fax: 44-20-7631-6803; E-mail: a.purkiss@mail.cryst.bbk.ac.uk.
Published, JBC Papers in Press, November 8, 2001, DOI 10.1074/jbc.M110083200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
HGSC, human
S-crystallin C-terminal domain;
BGBC, bovine
B-crystallin
C-terminal domain;
BGSC, bovine
S-crystallin C-domain.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Derham, B. K., and Harding, J. J. (1999) Prog. Retinal Eye Res. 18, 463-509[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Horwitz, J. (2000) Semin. Cell Dev. Biol. 11, 53-60[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Das, K. P.,
Choo-Smith, L. P.,
Petrash, J. M.,
and Surewicz, W. K.
(1999)
J. Biol. Chem.
274,
33209-33212 |
| 4. | Slingsby, C., Norledge, B., Simpson, A., Bateman, O. A., Wright, G., Driessen, H. P. C., Lindley, P. F., Moss, D. S, and Bax, B. (1997) Prog. Ret. Eye Res. 16, 3-29 |
| 5. | Mayr, E.-M., Jaenicke, R., and Glockshuber, R. (1997) J. Mol. Biol. 269, 260-269[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Palme, S., Slingsby, C., and Jaenicke, R. (1997) Protein Sci. 6, 1529-1536[Abstract] |
| 7. | Trinkl, S., Glockshuber, R., and Jaenicke, R. (1994) Protein Sci. 3, 1392-1400[Abstract] |
| 8. | Bax, B., Lapatto, R., Nalini, V., Driessen, H., Lindley, P. F., Mahadevan, D., Blundell, T. L., and Slingsby, C. (1990) Nature 347, 776-780[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Lubsen, N. H., Aarts, H. J. M., and Schoenmakers, J. G. G. (1988) Prog. Biophys. Mol. Biol. 51, 47-76[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | de Jong, W. W., Lubsen, N. H., and Kraft, H. J. (1994) Prog. Retinal Eye Res. 13, 391-442[CrossRef] |
| 11. |
Broide, M. L.,
Berland, C. R.,
Pande, J.,
Ogun, O. O.,
and Benedek, G. B.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
5660-5664 |
| 12. | Tardieu, A., Vérétout, F., Krop, B., and Slingsby, C. (1992) Eur. Biophys. J. 21, 1-12[Medline] [Order article via Infotrieve] |
| 13. | Skouri-Panet, F., Bonneté, F., Prat, K., Bateman, O. A., Lubsen, N. H., and Tardieu, A. (2001) Biophys. Chem. 89, 65-76[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Chirgadze, Y. N., Driessen, H. P. C., Wright, G., Slingsby, C., Hay, R. E., and Lindley, P. F. (1996) Acta Crystallogr. Sect. D Biol. Crystallogr. 52, 712-721[CrossRef] |
| 15. | Norledge, B. V., Hay, R. E., Bateman, O. A., Slingsby, C., and Driessen, H. P. C. (1997) Exp. Eye Res. 65, 609-630[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Palme, S., Jaenicke, R., and Slingsby, C. (1998) Protein Sci. 7, 611-618[Abstract] |
| 17. | Palme, S., Jaenicke, R., and Slingsby, C. (1998) J. Mol. Biol. 279, 1053-1059[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Lampi, K. J., Ma, Z.,
Shih, M.,
Shearer, T. R.,
Smith, J. B.,
Smith, D. L.,
and David, L. L.
(1997)
J. Biol. Chem.
272,
2268-2275 |
| 19. | Wenk, M., Herbst, R., Hoeger, D., Kretschmar, M., Lubsen, N. H., and Jaenicke, R. (2000) Biophys. Chem. 86, 95-108[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Purkiss, A. G., Slingsby, C., and Goodfellow, J. M. (2000) Protein Peptide Lett 7, 211-217 |
| 21. | Hanson, S. R. A., Hasan, A., Smith, D. L., and Smith, J. B. (2000) Exp. Eye Res. 71, 195-207[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Hanson, S. R. A., Smith, D. L., and Smith, J. B. (1998) Exp. Eye Res. 67, 301-312[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Ma, Z., Hanson, S. R. A., Lampi, K. J., David, L. L., Smith, D. L., and Smith, J. B. (1998) Exp. Eye Res. 67, 21-30[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Aswad, D. W., Paranandi, M. V., and Schurter, B. T. (2000) J. Pharmacol. Biomed. Anal 21, 1129-1136 |
| 25. |
Basak, A. K.,
Kroone, R. C.,
Lubsen, N. H.,
Naylor, C. E.,
Jaenicke, R.,
and Slingsby, C.
(1998)
Protein Eng.
11,
337-344 |
| 26. | Hemmingsen, J. M., Gernert, K. M., Richardson, J. S., and Richardson, D. C. (1994) Protein Sci. 3, 1927-1937[Abstract] |
| 27. | Bagby, S., Go, S., Inouye, S., Ikura, M., and Chakrabartty, A. (1998) J. Mol. Biol. 276, 669-681[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | Hamill, S. J., Cota, E., Chothia, C., and Clarke, J. (2000) J. Mol. Biol. 295, 641-649[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Powell, H. R. (1999) Acta Cryst. D55, 1690-1695 |
| 30. | Evans, P. R. (1997) in Proceedings of CCP4 Study Weekend on Recent Advances in Phasing, August 1997 (Wilson, K. S. , Davies, G. , Ashkon, A. W. , and Bailey, S., eds) , pp. 97-102, CCLRC, Daresbury Laboratory, Warrington, UK |
| 31. | French, G. S., and Wilson, K. S. (1978) Acta Crystallogr. Sect. A 34, 517-525[CrossRef] |
| 32. | Navaza, J. (1994) Acta Crystallogr. Sect. A 50, 157-163[CrossRef] |
| 33. | Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J.-S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Acta Crystallogr. Sect. D Biol. Crystallogr. 54, 905-921[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Jones, T. A., Zou, J.-Y., Cowan, S. W., and Kjeldgaard, M. (1994) Acta Crystallogr. Sect. A 47, 110-119[CrossRef] |
| 35. | Collaborative Computational Project, Number 4. (1994) Acta Crystallogr. Sect. D Biol. Crystallogr. 50, 760-763[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Murshudov, G. N., Vagin, A. A., and Dodson, E. J. (1997) Acta Crystallogr. Sect. D Biol. Crystallogr. 53, 240-255[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Lamzin, V. S., and Wilson, K. S. (1997) Methods Enzymol. 277, 269-305[Medline] [Order article via Infotrieve] |
| 38. | Laskowski, R. A., MacArthur, M. W., Moss, D. S., and Thornton, J. M. (1993) J. Appl. Crystallogr. 26, 283-291[CrossRef] |
| 39. | Hubbard, S. J., and Thornton, J. M. (1993) NACCESS , Computer Program, Department of Biochemistry and Molecular Biology, University College, London, UK |
| 40. | Koradi, R., Billeter, M., and Wüthrich, K. (1996) J. Mol. Graphics 14, 51-55[CrossRef][Medline] [Order article via Infotrieve] |
| 41. | Blundell, T., Lindley, P., Miller, L., Moss, D., Slingsby, C., Tickle, I., Turnell, B., and Wistow, G. (1981) Nature 289, 771-777[CrossRef][Medline] [Order article via Infotrieve] |
| 42. | Norledge, B. V., Mayr, E.-M., Glockshuber, R., Bateman, O. A., Slingsby, C., Jaenicke, R., and Driessen, H. P. C. (1996) Nat. Struct. Biol. 3, 267-274[CrossRef][Medline] [Order article via Infotrieve] |
| 43. | Purkiss, A. G. (1999) Contax: Protein Distance Difference Plots (luing.cryst.bbk.ac.uk/bpurk01/work/contax 2.html) |
| 44. | Takemoto, L., and Boyle, D. (2000) Mol. Vision 6, 164-168[Medline] [Order article via Infotrieve] |
| 45. |
Sinha, D.,
Wyatt, M. K.,
Sarra, R.,
Jaworski, C.,
Slingsby, C.,
Thaung, C.,
Pannell, L.,
Robison, W. G.,
Favor, J.,
Lyon, M.,
and Wistow, G.
(2001)
J. Biol. Chem.
276,
9308-9315 |
| 46. |
Takemoto, L,
and Boyle, D.
(2000)
J. Biol. Chem.
275,
26109-26112 |
| 47. | Takemoto, L., Fujii, N., and Boyle, D. (2001) Exp. Eye Res 72, 559-563[CrossRef][Medline] [Order article via Infotrieve] |
| 48. |
Geiger, T.,
and Clarke, S.
(1987)
J. Biol. Chem.
262,
785-794 |
This article has been cited by other articles:
![]() |
I. A. Mills, S. L. Flaugh, M. S. Kosinski-Collins, and J. A. King Folding and stability of the isolated Greek key domains of the long-lived human lens proteins {gamma}D-crystallin and {gamma}S-crystallin Protein Sci., November 1, 2007; 16(11): 2427 - 2444. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wu, F. Delaglio, K. Wyatt, G. Wistow, and A. Bax Solution structure of {gamma}S-crystallin by molecular fragment replacement NMR Protein Sci., December 1, 2005; 14(12): 3101 - 3114. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||